Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.
Rodríguez-Leyva I, Calderón-Garcidueñas AL, Jiménez-Capdeville ME, Rentería-Palomo AA, Hernandez-Rodriguez HG, Valdés-Rodríguez R, Fuentes-Ahumada C, Torres-Álvarez B, Sepúlveda-Saavedra J, Soto-Domínguez A, Santoyo ME, Rodriguez-Moreno JI, Castanedo-Cázares JP. Rodríguez-Leyva I, et al. Among authors: fuentes ahumada c. Ann Clin Transl Neurol. 2014 Jul;1(7):471-8. doi: 10.1002/acn3.78. Epub 2014 Jul 1. Ann Clin Transl Neurol. 2014. PMID: 25356418 Free PMC article.
Repigmentation patterns induced by NB-UVB and their relationship with melanocytic migration and proliferation in vitiligo.
Castanedo-Cázares JP, Cortés-García JD, Fuentes-Ahumada C, Martinez-Rosales K, Torres-Álvarez B. Castanedo-Cázares JP, et al. Among authors: fuentes ahumada c. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):269-275. doi: 10.1111/phpp.12275. Epub 2016 Oct 5. Photodermatol Photoimmunol Photomed. 2016. PMID: 27627998 Clinical Trial.
[Assessment of moisturizing creams available in México].
Hernández-Barrera NR, Moncada B, Navarrete-Solís J, Fuentes-Ahumada C, Torres-Álvarez B, Castanedo-Cázares JP, Cano-Ríos P. Hernández-Barrera NR, et al. Among authors: fuentes ahumada c. Gac Med Mex. 2011 May-Jun;147(3):270-4. Gac Med Mex. 2011. PMID: 21743598 Clinical Trial. Spanish.
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.
Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ, Martínez-Ramírez JD, Moncada B. Navarrete-Solís J, et al. Among authors: fuentes ahumada c. Dermatol Res Pract. 2011;2011:379173. doi: 10.1155/2011/379173. Epub 2011 Jul 21. Dermatol Res Pract. 2011. PMID: 21822427 Free PMC article.
Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study.
Castanedo-Cazares JP, Lárraga-Piñones G, Ehnis-Pérez A, Fuentes-Ahumada C, Oros-Ovalle C, Smoller BR, Torres-Álvarez B. Castanedo-Cazares JP, et al. Among authors: fuentes ahumada c. Clin Cosmet Investig Dermatol. 2013;6:29-36. doi: 10.2147/CCID.S39246. Epub 2013 Jan 14. Clin Cosmet Investig Dermatol. 2013. PMID: 23355788 Free PMC article.
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.
Campuzano-García AE, Torres-Alvarez B, Hernández-Blanco D, Fuentes-Ahumada C, Cortés-García JD, Castanedo-Cázares JP. Campuzano-García AE, et al. Among authors: fuentes ahumada c. Biomed Res Int. 2019 Apr 22;2019:9068314. doi: 10.1155/2019/9068314. eCollection 2019. Biomed Res Int. 2019. PMID: 31143777 Free PMC article. Clinical Trial.
14 results